Loading…
Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway
Background Patients with pancreatic cancer have a dismal prognosis due to tumor cell infiltration and metastasis. Many reports have documented that EMT and PI3K–AKT–mTOR axis control pancreatic cancer cell infiltration and metastasis. Chloroxine is an artificially synthesized antibacterial compound...
Saved in:
Published in: | Clinical & translational oncology 2024-04, Vol.26 (4), p.951-965 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c298t-f3eec676f4d42c86e57b43b94cbd020f24c115cd77a6ecc4fb24f7843ebe144d3 |
container_end_page | 965 |
container_issue | 4 |
container_start_page | 951 |
container_title | Clinical & translational oncology |
container_volume | 26 |
creator | Lin, Miaomiao Xiao, Yanyi Dai, Yile Mao, Yefan Xu, Liming Zhang, Qiyu Chen, Zhe |
description | Background
Patients with pancreatic cancer have a dismal prognosis due to tumor cell infiltration and metastasis. Many reports have documented that EMT and PI3K–AKT–mTOR axis control pancreatic cancer cell infiltration and metastasis. Chloroxine is an artificially synthesized antibacterial compound that demonstrated anti-pancreatic cancer effects in our previous drug-screening trial. We have explored the impact of chloroxine on pancreatic cancer growth, infiltration, migration, and apoptosis.
Methods
The proliferation of pancreatic cancer cell lines (PCCs) treated with chloroxine was assessed through real-time cell analysis (RTCA), colony formation assay, CCK-8 assay, as well as immunofluorescence. Chloroxine effects on the infiltrative and migratory capacities of PCCs were assessed via Transwell invasion and scratch experiments. To assess the contents of EMT- and apoptosis-associated proteins in tumor cells, we adopted Western immunoblotting as well as immunofluorescence assays, and flow cytometry to determine chloroxine effects on PCCs apoptosis. The in vivo chloroxine antineoplastic effects were explored in nude mice xenografts.
Results
Chloroxine repressed pancreatic cancer cell growth, migration, and infiltration in vitro, as well as in vivo, and stimulated apoptosis of the PCCs. Chloroxine appeared to inhibit PCC growth by Ki67 downregulation; this targeted and inhibited aberrant stimulation of the PI3K–AKT–mTOR signaling cascade, triggered apoptosis in PCC via mitochondria-dependent apoptosis, and modulated the EMT to inhibit PCC infiltration and migration.
Conclusions
Chloroxine targeted and inhibited the PI3K–AKT–mTOR cascade to repress PCCs growth, migration, as well as invasion, and triggered cellular apoptosis. Therefore, chloroxine may constitute a potential antineoplastic drug for the treatment of pancreatic cancer. |
doi_str_mv | 10.1007/s12094-023-03328-w |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2878709565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2878709565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-f3eec676f4d42c86e57b43b94cbd020f24c115cd77a6ecc4fb24f7843ebe144d3</originalsourceid><addsrcrecordid>eNp9kEtrGzEUhUVoiZ20f6CLomU3U-s1r6UxTWMScAnOWmg0d2YUxpIraXDSXx-ldkJWWd0D95wD50PoGyU_KSHlIlBGapERxjPCOauywxma06KuM07y_NM7PUMXITyQpApKz9GMl5Woijqfo8fVMDrvHo0FbOxgGhMD3iurPahoNNZJgsd773oPIRhncRy8m_oBR-V7iNBiZaPqnTX_UiL9XZcsgP-s-c1iebNd7LabOxxMb9VobJ_K43BQT1_Q506NAb6e7iW6v_q1XV1nt5vf69XyNtOsrmLWcQBdlEUnWsF0VUBeNoI3tdBNSxjpmNCU5rotS1WA1qJrmOjSOg4NUCFafol-HHvThL8ThCh3JmgYR2XBTUGyqqxKUudFnqzsaNXeheChk3tvdso_SUrkC3F5JC4TcfmfuDyk0PdT_9TsoH2LvCJOBn40hPSyPXj54CafYISPap8ByryPWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2878709565</pqid></control><display><type>article</type><title>Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway</title><source>Springer Link</source><creator>Lin, Miaomiao ; Xiao, Yanyi ; Dai, Yile ; Mao, Yefan ; Xu, Liming ; Zhang, Qiyu ; Chen, Zhe</creator><creatorcontrib>Lin, Miaomiao ; Xiao, Yanyi ; Dai, Yile ; Mao, Yefan ; Xu, Liming ; Zhang, Qiyu ; Chen, Zhe</creatorcontrib><description>Background
Patients with pancreatic cancer have a dismal prognosis due to tumor cell infiltration and metastasis. Many reports have documented that EMT and PI3K–AKT–mTOR axis control pancreatic cancer cell infiltration and metastasis. Chloroxine is an artificially synthesized antibacterial compound that demonstrated anti-pancreatic cancer effects in our previous drug-screening trial. We have explored the impact of chloroxine on pancreatic cancer growth, infiltration, migration, and apoptosis.
Methods
The proliferation of pancreatic cancer cell lines (PCCs) treated with chloroxine was assessed through real-time cell analysis (RTCA), colony formation assay, CCK-8 assay, as well as immunofluorescence. Chloroxine effects on the infiltrative and migratory capacities of PCCs were assessed via Transwell invasion and scratch experiments. To assess the contents of EMT- and apoptosis-associated proteins in tumor cells, we adopted Western immunoblotting as well as immunofluorescence assays, and flow cytometry to determine chloroxine effects on PCCs apoptosis. The in vivo chloroxine antineoplastic effects were explored in nude mice xenografts.
Results
Chloroxine repressed pancreatic cancer cell growth, migration, and infiltration in vitro, as well as in vivo, and stimulated apoptosis of the PCCs. Chloroxine appeared to inhibit PCC growth by Ki67 downregulation; this targeted and inhibited aberrant stimulation of the PI3K–AKT–mTOR signaling cascade, triggered apoptosis in PCC via mitochondria-dependent apoptosis, and modulated the EMT to inhibit PCC infiltration and migration.
Conclusions
Chloroxine targeted and inhibited the PI3K–AKT–mTOR cascade to repress PCCs growth, migration, as well as invasion, and triggered cellular apoptosis. Therefore, chloroxine may constitute a potential antineoplastic drug for the treatment of pancreatic cancer.</description><identifier>ISSN: 1699-3055</identifier><identifier>EISSN: 1699-3055</identifier><identifier>DOI: 10.1007/s12094-023-03328-w</identifier><identifier>PMID: 37848695</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Medicine ; Medicine & Public Health ; Oncology ; Research Article</subject><ispartof>Clinical & translational oncology, 2024-04, Vol.26 (4), p.951-965</ispartof><rights>The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-f3eec676f4d42c86e57b43b94cbd020f24c115cd77a6ecc4fb24f7843ebe144d3</cites><orcidid>0000-0001-8528-6340 ; 0000-0001-5463-6459</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37848695$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, Miaomiao</creatorcontrib><creatorcontrib>Xiao, Yanyi</creatorcontrib><creatorcontrib>Dai, Yile</creatorcontrib><creatorcontrib>Mao, Yefan</creatorcontrib><creatorcontrib>Xu, Liming</creatorcontrib><creatorcontrib>Zhang, Qiyu</creatorcontrib><creatorcontrib>Chen, Zhe</creatorcontrib><title>Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway</title><title>Clinical & translational oncology</title><addtitle>Clin Transl Oncol</addtitle><addtitle>Clin Transl Oncol</addtitle><description>Background
Patients with pancreatic cancer have a dismal prognosis due to tumor cell infiltration and metastasis. Many reports have documented that EMT and PI3K–AKT–mTOR axis control pancreatic cancer cell infiltration and metastasis. Chloroxine is an artificially synthesized antibacterial compound that demonstrated anti-pancreatic cancer effects in our previous drug-screening trial. We have explored the impact of chloroxine on pancreatic cancer growth, infiltration, migration, and apoptosis.
Methods
The proliferation of pancreatic cancer cell lines (PCCs) treated with chloroxine was assessed through real-time cell analysis (RTCA), colony formation assay, CCK-8 assay, as well as immunofluorescence. Chloroxine effects on the infiltrative and migratory capacities of PCCs were assessed via Transwell invasion and scratch experiments. To assess the contents of EMT- and apoptosis-associated proteins in tumor cells, we adopted Western immunoblotting as well as immunofluorescence assays, and flow cytometry to determine chloroxine effects on PCCs apoptosis. The in vivo chloroxine antineoplastic effects were explored in nude mice xenografts.
Results
Chloroxine repressed pancreatic cancer cell growth, migration, and infiltration in vitro, as well as in vivo, and stimulated apoptosis of the PCCs. Chloroxine appeared to inhibit PCC growth by Ki67 downregulation; this targeted and inhibited aberrant stimulation of the PI3K–AKT–mTOR signaling cascade, triggered apoptosis in PCC via mitochondria-dependent apoptosis, and modulated the EMT to inhibit PCC infiltration and migration.
Conclusions
Chloroxine targeted and inhibited the PI3K–AKT–mTOR cascade to repress PCCs growth, migration, as well as invasion, and triggered cellular apoptosis. Therefore, chloroxine may constitute a potential antineoplastic drug for the treatment of pancreatic cancer.</description><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Research Article</subject><issn>1699-3055</issn><issn>1699-3055</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kEtrGzEUhUVoiZ20f6CLomU3U-s1r6UxTWMScAnOWmg0d2YUxpIraXDSXx-ldkJWWd0D95wD50PoGyU_KSHlIlBGapERxjPCOauywxma06KuM07y_NM7PUMXITyQpApKz9GMl5Woijqfo8fVMDrvHo0FbOxgGhMD3iurPahoNNZJgsd773oPIRhncRy8m_oBR-V7iNBiZaPqnTX_UiL9XZcsgP-s-c1iebNd7LabOxxMb9VobJ_K43BQT1_Q506NAb6e7iW6v_q1XV1nt5vf69XyNtOsrmLWcQBdlEUnWsF0VUBeNoI3tdBNSxjpmNCU5rotS1WA1qJrmOjSOg4NUCFafol-HHvThL8ThCh3JmgYR2XBTUGyqqxKUudFnqzsaNXeheChk3tvdso_SUrkC3F5JC4TcfmfuDyk0PdT_9TsoH2LvCJOBn40hPSyPXj54CafYISPap8ByryPWg</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Lin, Miaomiao</creator><creator>Xiao, Yanyi</creator><creator>Dai, Yile</creator><creator>Mao, Yefan</creator><creator>Xu, Liming</creator><creator>Zhang, Qiyu</creator><creator>Chen, Zhe</creator><general>Springer International Publishing</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8528-6340</orcidid><orcidid>https://orcid.org/0000-0001-5463-6459</orcidid></search><sort><creationdate>20240401</creationdate><title>Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway</title><author>Lin, Miaomiao ; Xiao, Yanyi ; Dai, Yile ; Mao, Yefan ; Xu, Liming ; Zhang, Qiyu ; Chen, Zhe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-f3eec676f4d42c86e57b43b94cbd020f24c115cd77a6ecc4fb24f7843ebe144d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Research Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Miaomiao</creatorcontrib><creatorcontrib>Xiao, Yanyi</creatorcontrib><creatorcontrib>Dai, Yile</creatorcontrib><creatorcontrib>Mao, Yefan</creatorcontrib><creatorcontrib>Xu, Liming</creatorcontrib><creatorcontrib>Zhang, Qiyu</creatorcontrib><creatorcontrib>Chen, Zhe</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical & translational oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Miaomiao</au><au>Xiao, Yanyi</au><au>Dai, Yile</au><au>Mao, Yefan</au><au>Xu, Liming</au><au>Zhang, Qiyu</au><au>Chen, Zhe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway</atitle><jtitle>Clinical & translational oncology</jtitle><stitle>Clin Transl Oncol</stitle><addtitle>Clin Transl Oncol</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>26</volume><issue>4</issue><spage>951</spage><epage>965</epage><pages>951-965</pages><issn>1699-3055</issn><eissn>1699-3055</eissn><abstract>Background
Patients with pancreatic cancer have a dismal prognosis due to tumor cell infiltration and metastasis. Many reports have documented that EMT and PI3K–AKT–mTOR axis control pancreatic cancer cell infiltration and metastasis. Chloroxine is an artificially synthesized antibacterial compound that demonstrated anti-pancreatic cancer effects in our previous drug-screening trial. We have explored the impact of chloroxine on pancreatic cancer growth, infiltration, migration, and apoptosis.
Methods
The proliferation of pancreatic cancer cell lines (PCCs) treated with chloroxine was assessed through real-time cell analysis (RTCA), colony formation assay, CCK-8 assay, as well as immunofluorescence. Chloroxine effects on the infiltrative and migratory capacities of PCCs were assessed via Transwell invasion and scratch experiments. To assess the contents of EMT- and apoptosis-associated proteins in tumor cells, we adopted Western immunoblotting as well as immunofluorescence assays, and flow cytometry to determine chloroxine effects on PCCs apoptosis. The in vivo chloroxine antineoplastic effects were explored in nude mice xenografts.
Results
Chloroxine repressed pancreatic cancer cell growth, migration, and infiltration in vitro, as well as in vivo, and stimulated apoptosis of the PCCs. Chloroxine appeared to inhibit PCC growth by Ki67 downregulation; this targeted and inhibited aberrant stimulation of the PI3K–AKT–mTOR signaling cascade, triggered apoptosis in PCC via mitochondria-dependent apoptosis, and modulated the EMT to inhibit PCC infiltration and migration.
Conclusions
Chloroxine targeted and inhibited the PI3K–AKT–mTOR cascade to repress PCCs growth, migration, as well as invasion, and triggered cellular apoptosis. Therefore, chloroxine may constitute a potential antineoplastic drug for the treatment of pancreatic cancer.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>37848695</pmid><doi>10.1007/s12094-023-03328-w</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0001-8528-6340</orcidid><orcidid>https://orcid.org/0000-0001-5463-6459</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1699-3055 |
ispartof | Clinical & translational oncology, 2024-04, Vol.26 (4), p.951-965 |
issn | 1699-3055 1699-3055 |
language | eng |
recordid | cdi_proquest_miscellaneous_2878709565 |
source | Springer Link |
subjects | Medicine Medicine & Public Health Oncology Research Article |
title | Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A12%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chloroxine%20inhibits%20pancreatic%20cancer%20progression%20through%20targeted%20antagonization%20of%20the%20PI3K/AKT/mTOR%20signaling%20pathway&rft.jtitle=Clinical%20&%20translational%20oncology&rft.au=Lin,%20Miaomiao&rft.date=2024-04-01&rft.volume=26&rft.issue=4&rft.spage=951&rft.epage=965&rft.pages=951-965&rft.issn=1699-3055&rft.eissn=1699-3055&rft_id=info:doi/10.1007/s12094-023-03328-w&rft_dat=%3Cproquest_cross%3E2878709565%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c298t-f3eec676f4d42c86e57b43b94cbd020f24c115cd77a6ecc4fb24f7843ebe144d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2878709565&rft_id=info:pmid/37848695&rfr_iscdi=true |